2在HSA网站上注册账户:访问HSA的官方网站(https://wwwhsa新加坡HSA注册是指在新加坡卫生科学局(Health Sciences Authority,简

以下是HSA官 方网站的网址:https://wwwhsa新加坡HSA注册+新代,医疗器械CE认证+欧代,美国FDA认证+美代,澳大利亚TGA注册+澳代,英国UKCA认证+英代新加坡HSA(卫生科学局)注册的申请过程通常包括多个步骤,具体步骤和要求会因您申请的产品或服务类型而有所不同

切换导航新加坡HSA医疗器械注册返回 Back新加坡HSA医疗器械注册Health SciencesAuthority

HSA is the national authority regulating health products; managing the national blood bank, transfusion medicine and forensic medicine expertise; and providing critical forensic and analytical laboratory services& HSA We serve the administration of justice with the use of forensic medicine, forensic science and analytical chemistry testing We secure the nation's blood supply by ensuring a safe and adequate blood supply for public and private hospitals We regulate health products to meet standards of safety, quality and efficacy Government of Singapore Last Updated03 Sep 2019 Im

The HSA-NPRA Generic Medicines Work Sharing Initiative is a work sharing model for the joint collaborative assessment of a generic medicine registration application filed with both the Health Sciences Authority (HSA) of Singapore and the National Pharmaceutical Regulatory Agency (NPRA) of Malaysia This initiative aims to enhance leveraging regulatory expertise, reduce regulatory burden and facilitate market entry of generic medicines As a pilot, we are looking for a potential candidate of an immediate release oral solid dosage form supported by bioequivalence data Please refer to th

申请应通过电子邮件地址hsa_md_info@hsa 提交2022 年 6 月 29 日,新加坡卫生科学局 (HSA) 发布了对指导文件 GN-32 新加坡展览进口未注册医疗器械指南修订版 4 的更新

多国认证注册中新加坡卫生科学局(HSA)注册申请提交资料或技术文件是基于东盟CSDT(普通提交材料格式)文件格式的,所提交的材料中要求的信息取决于您的医疗器械分类以及所选择的评估路径,来自欧盟技术文件的文件资料多半是可以用来满足许多佐证文件资料要求的,必须按照基本原则来准备合规性声明,一旦获得批准,产品将会列入新加坡医疗器械目录(SMDR)数据库中。多国认证注册中对于巴西非

You will need to register your therapeutic products and apply for a licence before you import, manufacture or wholesale them in Singapore Find out what are the requirements Skip to main contentProducts regulationDecrease font sizeIncrease font sizeSearchE-servicesProduct Regulations Medical devicesTherapeutic productsHealth supplementsTraditional medicinesChinese proprietary medicinesCosmetic productsTobacco regulationMore Regulations Active ingredientsClinical trials​Controlled drugs and psychotropic substancesHomoeopathic medicinesMedicated oils, balms and medi

新加坡卫生科学局(HSA)已从2025年05月13日开始实施新的医疗器械监管改革。新加坡的医疗器械市场监管机构已从2025年05月13日开始实施重要的监管改革,受影响的领域包括低风险器械、远程医疗产品和质量体系要求。

原标题:华大基因:关于全资子公司产品获得新加坡HSA临时授权的公告 证券代码:证券简称:华大基因公告编号:2020-063 深圳华大基因股份有限公司 关于全资子公司产品获得新加坡HSA临时授权的公告 本公司及董事会全体 深圳华大基因股份有限公司(以下简称“公司”)全资子公司BGI Health (SG) Company Pte Ltd(以下简称“新加坡华大”)于近日收到新加坡卫生科学局(英 文全称“Health Sciences Autho